Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer

Combination therapy with Notch and CDK4/6 inhibitors for the treatment of cancer

US Patent 11298362 · Granted Apr 12, 2022

Estimated economic value: $941,318,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combination therapy with notch and PD-1 or PD-L1 inhibitors2023
Combination therapy with Notch and PI3K/mTOR inhibitors for use in treating canc2023
(E)-1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl 4-((3-isopropyl-5-methylpyra2020
Combination therapy with Notch and PD-1 or PD-L1 inhibitors2020
Notch pathway signaling inhibitor compounds2019
Disubstituted phthalazine hedgehog pathway antagonists2015
Disubstituted phthalazine hedgehog pathway antagonists2012
Modulation of survivin expression2009
Attenuated and dominant negative variant cDNAs of Stat6: Stat6b and Stat6c2002
Protein kinase which specifically phosphorylates BRCA-11999